Mr Mrs Miss Ms Dr Other

Ms
Esmae
Badcock

Trainee Patent Attorney

London Office

Life sciences

Telephone. +44(0) 207 776 5145
Email. ebadcock@hgf.com
Vcard
Linkedin

Experience

Esmae graduated from the University of Birmingham with a first class honours degree in Natural Sciences (Biochemistry major) with a year abroad at ETH and UZH in Switzerland.

She has a broad bioscience background and studied in the areas of biophysics, biomaterials, neuroscience, omics for personalised medicine, and biochemistry, where she achieved the highest mark in the module Chemistry for Biochemists and mainly focused on genetics and biologic therapeutics.

Whilst studying at UZH, she completed a lab project investigating the anchor cell as a model for the initiation of tumour cell metastasis using gene therapies alongside CRISPR/Cas9 technology. In her final year, she completed an interdisciplinary research project investigating bioink formulations for in situ bone tissue regeneration.

Specialisms

Industries

Services

Qualifications

Trainee

BSC

(Hons) Natural Sciences (Biochemistry)

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article
Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us